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explant culture and mouse embryonic stem cell culture and the
results will be presented.
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Immortalized mouse epicardial cells undergo
differentiation in response to transforming growth factor-β
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TGFβ induces loss of epithelial character and smooth muscle
differentiation in primary epicardial cells from chick and mouse.
To facilitate the study of TGFβ signaling in epicardial cells we
generated immortalized mouse cell lines. Epicardial cells were
isolated from a transgenic mouse where the large T antigen is
temperature regulated (Jat et al., PNAS USA. 88:5096-5100,
1991). Cells can be maintained and expanded at 33 °C and at
37 °C large T antigen expression is silenced. Hearts from mouse
embryos at E11.5 were placed on collagen-coated slides for 12 h
at 37 °C, the hearts removed, and the culture incubated at 33 °C.
Cells grew as tightly packed epithelium and were expanded for
storage in liquid nitrogen or replated. To date, 2 cell lines have
been in culture for over 6 months. These cells respond to TGFβ.
Cells were replated and incubated at 37 °C for 24 h prior to the
addition of 250 pM TGFβ1 or TGFβ2. Each induced the loss of
epithelial morphology as monitored by the loss of Zonula
Occludens-1 (ZO-1) at 72 h. TGFβ1 or TGFβ2 also induced the
smooth muscle markers SM22α and calponin. Inhibition of
activin receptor-like kinase (ALK) 5 by 2.5 μM SB431542
blocked all effects of TGFβ1 or TGFβ2. These data suggest that
immortalized epicardial cells are a suitable model for studying the
signaling mechanism by which TGFβ induces differentiation.
Source: HL67105(JVB), HL076133(AFA), AHA0655129
(JVB), and GM07347(LAC).
doi:10.1016/j.ydbio.2007.03.643
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Co-operative and synergistic actions of Tbx5 and MRTF-B
in zebrafish cardiogenesis
Shuhei Kakizaki, Yasuyuki Kida, Keiko Ogura,
Toshihiko Ogura
1 Inst. of Dev., Aging and Cancer, Tohoku Univ., Japan
2 Dept. of Pediatrics, Tohoku Univ., Japan
Members of the T-box family play fundamental roles during
pattern formation of vertebrate hearts. However, the transcrip-tional machinery of Tbx5 protein has not been explored in
detail. In search of co-activator(s) for Tbx5, we have found that
one of the Myocardin family co-operates with Tbx5 to activate
ANF promoter. In our transcriptional activation assay using the
ANF promoter, Tbx5 and MRTF-B activate it more than 250
fold in a synergistic manner. We also found that MRTF-B forms
a complex with Tbx5. Formation of this complex was enhanced
by serum stimulation, and MRTF-B changes its sub-cellular
localization. We performed knock-down experiments using
antisense morpholino oligos (MOs). In the morphants, heart-
looping defects were observed with stagnation of blood flow.
We also observed decreased expression of ANF, as well as
abnormal cell behaviors during dynamic movement of cardio-
myocytes. We next performed co-injection of a cmlc2=EGFP
construct along with the MRTF MOs to observe behaviors of
cardiomyocytes during heart looping. In this experiment, the
dynamic movement of cardiomyocytes was severely affected,
compared with the wild type. Surprisingly, sub-cellular loca-
lization of MRTF is dependent on beating of heart; when heart is
beating, MRTF is in the nucleus, whereas shuttles out to the
cytoplasm when heart beating is arrested. This suggests that
mechanical stress induced by beating per se is an epigenetic
factor that controls cardiac development, highlighting MRTF as
a molecule that links physical forces and genomic responses.
doi:10.1016/j.ydbio.2007.03.644
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Teratogenic effects of folic acid deficiency induced by
methotrexate in heart development in a rat model
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Mexico has a long history in neural tube defects (NTD). One
of NTD's cause is the folic acid (FA) deficit. The Mexican
people have diverse risk factors for FA deficiency. The con-
genital heart defects (CHD) are the 1st cause of the infantile
mortality in Mexico. The FA deficiency would be considered as
risk factor for CHD, therefore we proposed to develop an
experimental model that checks it. Methotrexate (MTX) acts by
inhibiting the DHFR.Method: Transversal study in 55 pregnant
Wistar rats; they were distributed in 5 groups: controls and
experimental groups (injection 9th, 10th and 12th), divided in 3
subgroups (MTX ip 0.12, 0.25 and 0.5 mg/kg). An external
analysis of the heart and great arteries was done. The internal
structure evaluation of the heart was made by a four chamber
cut and measured with a micrometric objective; finally a
photographic register was made. Results:We obtained 352 alive
fetus, 23 dead fetus and 207 reabsortions. It was found 23% of
external alterations, 24.4% of internal alterations and 16.2% of
CHD, as atrial septal defects, ventricular septal defects, veins
and great arteries alterations, aortic ring, aortic coarctaction and
418 ABSTRACTS / Developmental Biology 306 (2007) 411–426tetralogy of Fallot. Conclusion: The most susceptible period in
the rat at the toxicity by FA deficiency induced by MTX was in
the 9th and 10th day and at dose of 0.25 and 0.5 mg/kg. The
deficiency of FA is a risk factor for develop CHD. The
proportion obtained for CHD was 16% and a ratio of 1:5. This
study gives a useful model for damage mechanisms experi-
mentation produces for FA deficit.
doi:10.1016/j.ydbio.2007.03.645Program/Abstract # 354
Regulation of the Snail family of transcription factors by
the Notch and TGF-β pathways during heart development
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The Notch and TGF-β signaling pathways have been shown
to play important roles in regulating endothelial-to-mesenchy-
mal transition (EMT). This process is required during cardiac
cushion development and generates cells that contribute to the
connective tissue of the valves and septa of the adult heart. We
show that the Notch pathway, via CSL, directly binds and
regulates expression of the Snail2 promoter in endothelial cells.
We show that Snail2 is required for Notch mediated EMT, binds
to and represses the VE-cadherin promoter, and induces a motile
phenotype. While Notch does not directly regulate Snail1
expression, Notch and TGF-β act synergistically to regulate
expression of Snail1 in endothelial cells. Additionally we
demonstrate that Snail2 is expressed by the mesenchymal cells
and a subset of endocardial cells of the atrioventricular canal and
outflow tract during cardiac morphogenesis. Our data demon-
strate that Snail2-deficient mouse embryos display defects in the
initiation of cardiac cushion EMT at E9.5, which can be rescued
by exogenous TGF-β2. Snail2-deficiency is compensated for by
increased Snail1 expression after E9.5, restoring EMT and
allowing cardiac cushion EMT. Collectively our data demon-
strate that Notch signaling directly regulates Snail2, but not
Snail1, expression and that the combined expression of Snail2
and Snail1 is required for cardiac cushion morphogenesis.
doi:10.1016/j.ydbio.2007.03.646
Program/Abstract # 355
Shox2 is required for proper development of the murine
cardiac pacemaker
Ramon A. Espinoza-Lewis, Ling Yu, Yiping Chen
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Cell and Mol. Biol. Dept., Tulane Univ. New Orleans, LA, USAThe heart beat, process by which a steady blood flow is
achieved, is regulated by the pacemaker located within the sinus
node. Several molecular markers have been used to characterize
the sinus node. However, few genes so far described are
involved in its differentiation. Targeted mutation in the Short
stature homeobox gene 2 (Shox2) leads to cardiac edema and
irregular heart beat. Shox2 is expressed in the venous-atrial
junction (sinus node) beginning at E8.5, and the pattern remains
through embryogenesis. By E10.5 the venous valves of the
sinus node are forming and Shox2 expression extends to these
regions, also comprising the cardiac pacemaker. Shox2 null
mutation showed embryonic lethality around E11.5 and
histological analysis demonstrated that it leads to the formation
of hypoplastic venous valves, which likely results from a
decreased level of cell proliferation. In situ hybridization
showed a down-regulation of the pacemaker marker Hcn4, the
conduction system marker Tbx3, and the gap junction protein
Cx43 in the Shox2 mutant pacemaker region and venous
valves. Accordingly, ANF, a direct Tbx3 downstream target is
up-regulated. In contrast, the expression of the myogenic
differentiation markers, MLC2a, MLC2v, and cTnt is not
altered. Our results reveal an expression pattern of Shox2 in
the developing heart, restricted to the sinus venosus region,
including the pacemaker area. Histological analysis along with
that of molecular markers indicates that Shox2 plays a critical
role in the development and differentiation of pacemaker
cardiomyocytes.
Supported by an EIA grant from the AHA.
doi:10.1016/j.ydbio.2007.03.647
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The type III transforming growth factor beta receptor is
required for coronary vessel development
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Transforming Growth Factor Beta (TGFβ) Receptor III
(TGFβR3) binds all 3 TGFβ ligands and inhibin with high
affinity but lacks the serine/threonine kinase domain found in the
Type I and Type II receptors (TGFβR1, TGFβR2). TGFβR3
facilitates signaling via TGFβR1/TGFβR2 but also plays a
unique and nonredundant role in TGFβ signaling. Deletion of
Tgfbr3 revealed a requirement for Tgfbr3 during development
of the coronary vessels. Coronary vasculogenesis is significantly
impaired in null mice with few vessels evident and numerous,
persistent blood islands found throughout the epicardium.
Tgfbr3 null mice die at E14.5, the time when functional coro-
nary vasculature is required for embryo viability. However, in
null mice nascent coronary vessels attach to the aorta, form two
coronary ostia, and initiate smooth muscle recruitment by E14.
Analysis of earlier developmental stages revealed defects in the
epicardium. At E13.5 these defects include an irregular and
